JP2022515720A5 - - Google Patents
Info
- Publication number
- JP2022515720A5 JP2022515720A5 JP2021534203A JP2021534203A JP2022515720A5 JP 2022515720 A5 JP2022515720 A5 JP 2022515720A5 JP 2021534203 A JP2021534203 A JP 2021534203A JP 2021534203 A JP2021534203 A JP 2021534203A JP 2022515720 A5 JP2022515720 A5 JP 2022515720A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- referred
- sar
- peptide ligand
- cysteine residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1820316.6A GB201820316D0 (en) | 2018-12-13 | 2018-12-13 | Bicyclic peptide ligands specific for IL-17 |
| GB1820316.6 | 2018-12-13 | ||
| PCT/GB2019/053534 WO2020120978A1 (en) | 2018-12-13 | 2019-12-13 | Bicyclic peptide ligands specific for il-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022515720A JP2022515720A (ja) | 2022-02-22 |
| JP2022515720A5 true JP2022515720A5 (https=) | 2022-12-19 |
Family
ID=65146974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534203A Pending JP2022515720A (ja) | 2018-12-13 | 2019-12-13 | Ｉｌ－１７に特異的な二環式ペプチドリガンド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220024983A1 (https=) |
| EP (1) | EP3894007A1 (https=) |
| JP (1) | JP2022515720A (https=) |
| CN (1) | CN113474046A (https=) |
| GB (1) | GB201820316D0 (https=) |
| WO (1) | WO2020120978A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202106444WA (en) | 2018-12-19 | 2021-07-29 | Leo Pharma As | Amino-acid anilides as small molecule modulators of il-17 |
| GB201918557D0 (en) * | 2019-12-16 | 2020-01-29 | Bicycle Tx Ltd | Bicyclic peptide ligands specific for IL-17 |
| GB201918559D0 (en) * | 2019-12-16 | 2020-01-29 | Bicycle Tx Ltd | Bicyclic peptide ligands specific for IL-17 |
| GB201918558D0 (en) * | 2019-12-16 | 2020-01-29 | Bicycle Tx Ltd | Bicyclic peptide ligands specific for IL-17 |
| WO2021123767A1 (en) * | 2019-12-16 | 2021-06-24 | Bicycletx Limited | Bicyclic peptide ligands specific for il-17 |
| PE20230469A1 (es) | 2020-04-30 | 2023-03-14 | Janssen Pharmaceutica Nv | Imidazopiridazinas como moduladores de il-17 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| WO2006078161A1 (en) | 2005-01-24 | 2006-07-27 | Pepscan Systems B.V. | Binding compounds, immunogenic compounds and peptidomimetics |
| EP1963368B3 (en) | 2005-12-13 | 2020-06-10 | Eli Lilly And Company | Anti-il-17 antibodies |
| EP2653545A1 (en) | 2008-02-05 | 2013-10-23 | Bicycle Therapeutics Limited | Methods and compositions |
| US20110223169A1 (en) | 2008-11-26 | 2011-09-15 | Stern Michael E | Il-17 antibody inhibitor for treating dry eye |
| US20110293629A1 (en) | 2010-05-14 | 2011-12-01 | Bastid Jeremy | Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 Antagonists |
| US20130195868A1 (en) | 2010-06-24 | 2013-08-01 | Eleven Biotherapeutics, Inc. | Treating surface of the eye disorders |
| CN107148425B (zh) * | 2014-10-29 | 2021-08-03 | 拜斯科阿迪有限公司 | 对mt1-mmp特异性的双环肽配体 |
| EP3181146A1 (en) * | 2015-12-16 | 2017-06-21 | Ruprecht-Karls-Universität Heidelberg | Cyclic ntcp-targeting peptides and their uses as entry inhibitors |
| GB201600911D0 (en) * | 2016-01-18 | 2016-03-02 | Bicycle Therapeutics Ltd | Stabilized peptide derivatives |
| GB201810327D0 (en) * | 2018-06-22 | 2018-08-08 | Bicycletx Ltd | Peptide ligands for binding to IL-17 |
-
2018
- 2018-12-13 GB GBGB1820316.6A patent/GB201820316D0/en not_active Ceased
-
2019
- 2019-12-13 WO PCT/GB2019/053534 patent/WO2020120978A1/en not_active Ceased
- 2019-12-13 CN CN201980081501.8A patent/CN113474046A/zh active Pending
- 2019-12-13 US US17/309,627 patent/US20220024983A1/en not_active Abandoned
- 2019-12-13 EP EP19824377.6A patent/EP3894007A1/en not_active Withdrawn
- 2019-12-13 JP JP2021534203A patent/JP2022515720A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022515720A5 (https=) | ||
| JP2022514255A5 (https=) | ||
| JP2022517442A5 (https=) | ||
| JP2022512478A5 (https=) | ||
| JP2022518695A5 (https=) | ||
| JP2022517040A5 (https=) | ||
| JP2022513223A5 (https=) | ||
| JP2022514687A5 (https=) | ||
| JP2022517399A5 (https=) | ||
| JP2022517698A5 (https=) | ||
| JP2022544058A5 (https=) | ||
| JP2022532134A5 (https=) | ||
| JP2022513806A5 (https=) | ||
| JP2022542291A5 (https=) | ||
| JP2022518210A5 (https=) | ||
| JP2022514618A5 (https=) | ||
| JP2022552839A5 (https=) | ||
| FI3294345T3 (fi) | Tpp1-formulaatioita ja menetelmiä cln2-taudin hoitamiseksi | |
| JP2022546878A5 (https=) | ||
| FI3746467T3 (fi) | Muutetut lipidoidut relaksiinin b-ketjun peptidit ja niiden terapeuttinen käyttö | |
| JP2014534265A5 (https=) | ||
| JP2012506442A5 (https=) | ||
| JP2006514104A5 (https=) | ||
| WO2018067217A3 (en) | COMPOSITIONS COMPRISING SHORT PEPTIDES DERIVED FROM PEDF AND USES THEREOF | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 |